Is GAILF or JNJ a better dividend investment in 2026?

GAILF currently yields 3.03% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: JNJ offers higher current income.

What is the dividend yield difference between GAILF and JNJ?

GAILF has a forward dividend yield of 3.03% ($0.33/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 0.33 percentage points.

Home › Compare › GAILF vs JNJ

GAILF vs JNJ: Dividend Comparison 2026

GAILF yields 3.03% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 GAILF wins by $8.4K in total portfolio value

INVESTMENT

TIME HORIZON10 years

GAILF

● Live price

3.03%

Share price

$10.75

Annual div

$0.33

5Y div CAGR

11.2%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$28.5K

Annual income

$1,212.11

Full GAILF calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — GAILF vs JNJ

📍 GAILF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	GAILF	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, GAILF + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

GAILF pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GAILF

Annual income on $10K today (after 15% tax)

$257.28/yr

After 10yr DRIP, annual income (after tax)

$1,030.29/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, GAILF beats the other by $326.68/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GAILF + JNJ for your $10,000?

GAILF: 50%JNJ: 50%

100% JNJ50/50100% GAILF

Portfolio after 10yr

$24.2K

Annual income

$1,019.95/yr

Blended yield

4.21%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

GAILF

No analyst data

Altman Z

2.7

Piotroski

5/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GAILF buys

JNJ buys

No recent congressional trades found for GAILF or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricGAILFJNJ

Forward yield	3.03%	3.36% ✓
Annual dividend / share	$0.33	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	11.2% ✓	5.8%
Portfolio after 10y	$28.5K ✓	$20.0K
Annual income after 10y	$1,212.11 ✓	$827.78
Total dividends collected	$6.9K ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: GAILF vs JNJ ($10,000, DRIP)

Year	GAILF Portfolio	GAILF Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$11,037	$336.58	$10,676	$355.77	+$361.00 → GAILF
2	$12,195	$386.05	$11,407	$389.39	+$788.00 → GAILF
3	$13,492	$443.32	$12,198	$426.53	+$1.3K → GAILF
4	$14,946	$509.72	$13,056	$467.62	+$1.9K → GAILF
5	$16,579	$586.82	$13,987	$513.12	+$2.6K → GAILF
6	$18,416	$676.49	$14,998	$563.56	+$3.4K → GAILF
7	$20,487	$780.94	$16,098	$619.52	+$4.4K → GAILF
8	$22,823	$902.82	$17,295	$681.69	+$5.5K → GAILF
9	$25,466	$1,045.29	$18,599	$750.82	+$6.9K → GAILF
10	$28,461	$1,212.11	$20,022	$827.78	+$8.4K → GAILF

GAILF vs JNJ: Complete Analysis 2026

GAILF — Stock

GAIL (India) Limited operates as a natural gas processing and distribution company in India and internationally. The company operates through Transmission Services, Natural Gas Marketing, Petrochemicals, LPG and Other Liquid Hydrocarbons, and Other segments. It is involved in the transmission and marketing of natural gas to the power, fertilizer, industrial, automotive, petrochemicals, and domestic and commercial sectors. It also markets liquefied petroleum gas (LPG), propane, pentane, naphtha, mixed fuel oil, polyethylene, and polypropylene; and manufactures petrochemicals, such as high-density polyethylene and linear low-density polyethylene under the brand names of G-Lex and G-Lene. In addition, the company generates wind and solar power. Further, the company engages in the chartering of LNG vessels. The company owns and operates approximately 14,500 km of natural gas pipeline. Additionally, the company operates 5 gas processing plants, 2 petrochemicals plants, 10 LPG pumping/receiving stations, and 8 natural gas compressor stations. GAIL (India) Limited was incorporated in 1984 and is based in New Delhi, India.

Full GAILF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this GAILF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GAILF vs SCHD GAILF vs JEPI GAILF vs O GAILF vs KO GAILF vs MAIN GAILF vs ABBV GAILF vs MRK GAILF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.